Company Intelligence

Paige

Paige provides enterprise-grade artificial intelligence solutions, delivering specialized Paige Platform technology designed to optimize mission-critical workflows across pathology labs, health systems, and life-sciences organizations using digital slide workflows..

Headquarters
New York, United States
Website
paige.ai
Founded
2017
Status
Acquired
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

Paige is a Healthcare AI company based in New York, United States, founded in 2017.

Paige develops new York digital pathology AI company, acquired by Tempus in August 2025.

It serves pathology labs, health systems, and life-sciences organizations using digital slide workflows.

Verified founder profile on Brel: Razik Yousfi.

What it does

The technical focus of Paige is deploying Paige Platform across enterprise environments to resolve data and workflow bottlenecks in Artificial Intelligence for Pathology labs, health systems, and life-sciences organizations using digital slide workflows..

Who it serves

Pathology labs, health systems, and life-sciences organizations using digital slide workflows.

What it builds

Paige Platform

Why It Matters

Paige provides enterprise-grade artificial intelligence solutions, delivering specialized Paige Platform technology designed to optimize mission-critical workflows across pathology labs, health systems, and life-sciences organizations using digital slide workflows..

Products

Products and platforms connected to this company.

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Paige

Industry

Industries served

  • Digital Pathology

Capabilities

Paige's AI models applied deep learning to whole-slide images, identifying patterns in hematoxylin-and-eosin stained tissue and in immunohistochemistry markers relevant to cancer…

Features

AI-powered digital pathology software for cancer diagnosis and biomarker analysis on digitized tissue slides.

Integrations

Laboratories evaluating Paige under Tempus ownership should assess integration depth with their existing digital pathology infrastructure, not only model performance metrics.

Country

United States

Use cases

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • August 22, 2025: Tempus announced the acquisition of Paige for $81.25 million. Latest
  • Company founded 2017 · founded Source
  • Development 2017 · development Source
  • Acquisition 2025 · acquisition Source
  • Company status status Source

Frequently Asked Questions

What does Paige do?

Paige specializes in artificial intelligence, developing Paige Platform to support pathology labs, health systems, and life-sciences organizations using digital slide workflows. with scalable, production-grade technology.

Where is Paige based and when was it founded?

Paige is based in United States and was founded in 2017.

What are the main products offered by Paige?

The flagship platform from Paige is Paige Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Paige?

Paige primarily serves pathology labs, health systems, and life-sciences organizations using digital slide workflows. seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.